Answers are grounded in this paper and cite their sources.
Chronic damage in different renal diseases leads to a change in urinary and serum uromodulin (>sUmod). This indicates that sUmod plays an important role in the development of chronic kidney disease (CKD), and can probably be used as an early marker for detecting renal impairment. Purpose: to assess the role of sUmod as a marker for early CKD detection. Materials/Methods: A total of 207 patients were enrolled in this prospective observational study in the Clinic of Nephrology of the University Hospital "St. Ivan Rilski", Sofia, Bulgaria. The mean age of the patients was 56.81 ± 14.24 years, with the male/female ratio 99/108 (47.8% / 52.2%). Laboratory blood and urine tests, abdominal ultrasound with resistive index (RI) measurement and sUmod investigations were performed. Results: There was a strong negative correlation between sUmod and serum creatinine (r= -0.712, p<0.0001) and moderate correlation – with urea (r= -0.680, p<0.0001) and cystatin C (r= -0.680, p<0.0001). Correspondingly, a strong positive relationship with estimated glomerular filtration rate (r=0.713, p<0.0001) was found. Moderate negative correlations were found between sUmod, RI (r = -0.511, p<0.0001) and parathyroid hormone (r = -0.449, p<0.0001). Correlations between continuation of CKD or hypertension, systolic or diastolic blood pressure or 24-hour proteinuria with sUmod were significant but not strong(r < 0.7; p < 0.05 for all). Conclusions: sUmod correlates well with all commonly known markers of kidney damage, and its values decrease significantly with increasing CKD severity. It allows sUmod to be used as an early diagnostic marker for CKD.
No takes yet. Share an insight, caveat, or question.
Genov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: